Cargando…
Catecholamine physiology and its implications in patients with COVID-19
The risk factors for severe COVID-19 are diverse, yet closely resemble the clinical manifestations of catecholamine excess states (eg, hypertension, cardiovascular disease, immune dysregulation, and hyperglycaemia), suggesting a potentially common basis for disease. Unfortunately, severe illness (eg...
Autores principales: | Gubbi, Sriram, Nazari, Matthew A, Taieb, David, Klubo-Gwiezdzinska, Joanna, Pacak, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598304/ https://www.ncbi.nlm.nih.gov/pubmed/33128872 http://dx.doi.org/10.1016/S2213-8587(20)30342-9 |
Ejemplares similares
-
Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022) -
SAT555 Utility of (18)F-DOPA PET/CT in the Diagnosis of Medullary Thyroid Cancer in a Patient with Multiple Endocrine Neoplasia Type 2B
por: Varghese, Diana Grace, et al.
Publicado: (2023) -
The granting of emergency use designation to COVID-19 candidate vaccines: implications for COVID-19 vaccine trials
por: Singh, Jerome Amir, et al.
Publicado: (2021) -
Early short-term effects on catecholamine levels and pituitary function in patients with pheochromocytoma or paraganglioma treated with [(177)Lu]Lu-DOTA-TATE therapy
por: Gubbi, Sriram, et al.
Publicado: (2023) -
Novel Targeted Therapies for Metastatic Thyroid Cancer—A Comprehensive Review
por: Al-Jundi, Mohammad, et al.
Publicado: (2020)